KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Common Equity (2016 - 2025)

Cvs Health (CVS) has disclosed Common Equity for 17 consecutive years, with $75.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity changed 0.46% year-over-year to $75.4 billion, compared with a TTM value of $75.4 billion through Dec 2025, changed 0.46%, and an annual FY2025 reading of $75.4 billion, changed 0.46% over the prior year.
  • Common Equity was $75.4 billion for Q4 2025 at Cvs Health, up from $73.1 billion in the prior quarter.
  • Across five years, Common Equity topped out at $77.6 billion in Q2 2025 and bottomed at $71.2 billion in Q1 2021.
  • Average Common Equity over 5 years is $74.3 billion, with a median of $74.6 billion recorded in 2021.
  • The sharpest move saw Common Equity increased 8.69% in 2021, then fell 4.2% in 2022.
  • Year by year, Common Equity stood at $74.8 billion in 2021, then decreased by 4.1% to $71.8 billion in 2022, then grew by 6.78% to $76.6 billion in 2023, then fell by 1.18% to $75.7 billion in 2024, then dropped by 0.46% to $75.4 billion in 2025.
  • Business Quant data shows Common Equity for CVS at $75.4 billion in Q4 2025, $73.1 billion in Q3 2025, and $77.6 billion in Q2 2025.